Intuitive Surgical (NASDAQ:ISRG) had its target price cut by stock analysts at Citigroup to $507.00 in a research note issued to investors on Tuesday, MarketBeat.com reports. The brokerage currently has a “buy” rating on the medical equipment provider’s stock. Citigroup’s price target would suggest a potential upside of 29.67% from the company’s current price.
A number of other research analysts have also issued reports on the stock. Wedbush reissued a “buy” rating on shares of Intuitive Surgical in a research note on Tuesday, October 10th. Zacks Investment Research raised shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating and set a $437.00 target price for the company in a research note on Tuesday, December 12th. ValuEngine lowered shares of Intuitive Surgical from a “hold” rating to a “sell” rating in a research note on Friday, December 29th. Goldman Sachs Group reissued a “buy” rating on shares of Intuitive Surgical in a research note on Saturday, November 18th. Finally, Barclays reissued an “overweight” rating on shares of Intuitive Surgical in a research note on Friday, October 20th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $408.48.
Intuitive Surgical (NASDAQ:ISRG) traded up $9.12 during midday trading on Tuesday, hitting $390.99. 1,075,128 shares of the stock traded hands, compared to its average volume of 1,040,567. Intuitive Surgical has a 1-year low of $233.66 and a 1-year high of $452.00. The firm has a market cap of $43,670.00, a price-to-earnings ratio of 69.18, a PEG ratio of 4.71 and a beta of 0.50.
In related news, CFO Marshall Mohr sold 7,500 shares of the business’s stock in a transaction that occurred on Monday, February 5th. The shares were sold at an average price of $414.19, for a total value of $3,106,425.00. Following the sale, the chief financial officer now directly owns 13,816 shares in the company, valued at approximately $5,722,449.04. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Salvatore Brogna sold 6,082 shares of the business’s stock in a transaction that occurred on Friday, December 1st. The stock was sold at an average price of $397.61, for a total transaction of $2,418,264.02. Following the completion of the sale, the chief operating officer now owns 3,096 shares in the company, valued at $1,231,000.56. The disclosure for this sale can be found here. Insiders have sold a total of 77,292 shares of company stock worth $31,931,428 over the last 90 days. 2.20% of the stock is owned by insiders.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in ISRG. CWM LLC raised its holdings in shares of Intuitive Surgical by 200.0% in the 4th quarter. CWM LLC now owns 285 shares of the medical equipment provider’s stock worth $104,000 after purchasing an additional 190 shares in the last quarter. American National Bank raised its holdings in shares of Intuitive Surgical by 200.0% in the 4th quarter. American National Bank now owns 300 shares of the medical equipment provider’s stock worth $109,000 after purchasing an additional 200 shares in the last quarter. Spectrum Management Group Inc. raised its holdings in shares of Intuitive Surgical by 154.2% in the 4th quarter. Spectrum Management Group Inc. now owns 300 shares of the medical equipment provider’s stock worth $109,000 after purchasing an additional 182 shares in the last quarter. Trust Department MB Financial Bank N A raised its holdings in shares of Intuitive Surgical by 200.0% in the 4th quarter. Trust Department MB Financial Bank N A now owns 345 shares of the medical equipment provider’s stock worth $126,000 after purchasing an additional 230 shares in the last quarter. Finally, Cerebellum GP LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $127,000. Institutional investors and hedge funds own 34.82% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by American Banking News and is owned by of American Banking News. If you are reading this piece of content on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The correct version of this piece of content can be viewed at https://www.americanbankingnews.com/2018/02/06/citigroup-lowers-intuitive-surgical-isrg-price-target-to-507-00.html.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.